1. Home
  2. IRD
  3. IRD News

Latest OPUS GENETICS INC (IRD) News on March 14, 2025

Opus Genetics Announces Presentations at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting
IRD

GlobeNewswire

9 days ago

Opus Genetics Announces Presentations at Association for Research in Vision and Ophthalmology (ARVO) 2025 Meeting

Opus Genetics Announces FDA Fast Track and Enrollment Updates for Phentolamine Ophthalmic Solution 0.75% Programs
IRD

GlobeNewswire

16 days ago

Opus Genetics Announces FDA Fast Track and Enrollment Updates for Phentolamine Ophthalmic Solution 0.75% Programs

Opus Genetics Announces Updates on OPGx-LCA5 Clinical Program
IRD

GlobeNewswire

24 days ago

Opus Genetics Announces Updates on OPGx-LCA5 Clinical Program

IRD

GlobeNewswire

a month ago

Shareholder Group Led by Founder Mina Sooch Nominates Majority Slate of Director Candidates to the Board of Opus Genetics, Inc.

IRD

Argus Research

2 months ago

Daily – Vickers Top Buyers & Sellers for 12/31/2024

Opus Genetics Receives FDA Agreement Under Special Protocol Assessment for Phase 3 Trial of APX3330 in Diabetic Retinopathy
IRD

GlobeNewswire

3 months ago

Opus Genetics Receives FDA Agreement Under Special Protocol Assessment for Phase 3 Trial of APX3330 in Diabetic Retinopathy

Opus Genetics to Host Virtual KOL Event on OPGx-LCA5 as a Treatment for LCA5-Associated Inherited Retinal Disease on December 11, 2024
IRD

GlobeNewswire

3 months ago

Opus Genetics to Host Virtual KOL Event on OPGx-LCA5 as a Treatment for LCA5-Associated Inherited Retinal Disease on December 11, 2024

Opus Genetics reinstated with a Buy at H.C. Wainwright
IRD

TipRanks

4 months ago

Opus Genetics reinstated with a Buy at H.C. Wainwright

Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
IRD

GlobeNewswire

4 months ago

Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

The RD Fund Announces Ocuphire Pharma's Acquisition of Opus Genetics
IRD

PR Newswire

5 months ago

The RD Fund Announces Ocuphire Pharma's Acquisition of Opus Genetics

Share on Social Networks: